Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.

Slides:



Advertisements
Similar presentations
Transitional Cell Carcinoma of the Urinary Tract
Advertisements

Urothelial CA: Cancers of the Bladder, Ureter, and Renal Pelvis
RESULTS OF RADICAL SURGERY FOR CARCINOMA OF GALLBLADDER DR CHEUNG YUE SUN Department of Surgery Prince of Wales Hospital The Chinese University of Hong.
1 Renal Pelvis, Ureter, Bladder and Other Urinary.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Great Debates & Updates in GI Malignancies
Staging for Cervical Cancer Can be done under anaesthesia WHO recommends downstaging Aim is to obtain adequate Histological specimen for conformation (
Haematuria and Urinary Tract Tumours
Borderline Resectable Pancreatic Carcinoma
Advanced squamous cell carcinoma of the bladder, What is next? Saleh A. Binsaleh.
Tumors of the penis.
59 years old man Hx of stomach adenocarcinoma 20 years ago Hx of chemoradiotherapy cc:gross hematuria.
High-Grade T1 Bladder Cancer: A Clinical Quandary Daniel Canter, M.D. Assistant Professor of Urology Emory University presentation created for:
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Bladder Cancer R. Zenhäusern. Bladder cancer: Epidemiology Incidence:20/100000/year (Europe) Mortality:8-9/100000/year Fourth most common cancer in men.
LOGO UPPER URINARY TRACT T.C.C. Presented by: Dr.HashimNaji R3.
Dr. Abdelaty Shawky Dr. Gehan Mohamed
Management of Colorectal Liver Metastasis
IN THE NAME OF GOD.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Urinary tract pathology-2. Renal Cell Carcinoma RCC account for 2% to 3% of all cancers in adults and are classified into three major types: Clear cell.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
TUMORS OF THE KIDNEY. BACKGROUND Renal cell carcinoma (RCC) accounts for about 2% of all cancers, with a world-wide annual increase of %. The.
Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage % 5yrs survival stageII 60%
A REVISIT TO MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOUR (GIST) Joint Hospital Surgical Grand Round 17 Jan 2015 Grace Liu Pamela Youde Nethersole Eastern.
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
Urothelial Carcinoma: Cancer of the bladder, Ureter, Renal pelvis.
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
IMRT for the Treatment of Anal Cancer Kristen O’Donnell, MS3 December 12, 2007.
Surgical Management of Urothelial Carcinoma A 21 st Century Approach Douglas S. Scherr, M.D. Clinical Director, Urologic Oncology Weill Medical College.
Adult Medical-Surgical Nursing
Resection For Lung Metastases M62 Coloproctology Course.
In the name of God Isfahan medical school Shahnaz Aram MD.
BLADDER CANCER 1.What proportion of deaths from bladder cancer could be improved if we could do a cystectomy earlier in the right people? 2.Do we allow.
Slides last updated: March 2015 CRC: STAGING. How colorectal cancer (CRC) is staged 1 Stage describes the extent of cancer, and is one of the most important.
Failure of Treatment in Cervical Cancer Patients *Dr. Zohreh Yousefi fellow ship of gynecology oncology of Mashhad university Fatemeh Homaee, Marzieh.
T4 Colon Cancer and Laparoscopic Approach Gustavo Plasencia MD FACS, FASCRS Clinical Professor of Surgery Gustavo Plasencia MD FACS, FASCRS Clinical Professor.
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
Prostate Cancer Treatment: What’s Best For You?
Dr. Abdellatif Zayed Bladder Cancer.
Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.
Management of T1G3 Bladder cancer Dr Charles Chabert.
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
Bladder cancer is the second most common cancer of the genitourinary tract. The incidence is higher in whites than in African Americans. The average age.
Urinary Bladder Anatomical sites of the urinary bladder. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer,
H. Emama M.D.. (Radiation Therapy) By: H. Emami Assistant professor of Radiation Oncology, Isfahan University of Medical Sciences, Isfahan, IRAN.
TNM BLADDER CANCER STAGING Dr. Mahnaz Roayaei Radiation Oncologist Assistant Professor Isfahan University of Medical Sciences.
Neoplasms of the bladder
Contemporary Treatment Guidelines on Bladder Cancer
Bladder tumor dr,mohamed fawzi alshahwani 1. facts Bladder cancer is the second most common cancer of the genitourinary tract.Bladder cancer is the second.
By Dr. Abdelaty Shawky Assistant professor of pathology
 T1 tumors at high risk of progression (high grade, multifocality, CIS, and tumor size, )  In all T1 patients failing intravesical therapy  muscle-invasive.
Role of MRI in Primary Rectal Cancer Staging and Management
Trends in bladder cancer treatments
أورام المثانة Bladder cancer Dr.Alseoudi Alhadi د.الهادي السعودي Albairouni C.H.U.
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
Bladder Cancer Mark Browning, M.D. ‘ IUSME.
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer NEJM July vol 359 R2 임규성.
Carcinoma Vulva & Vagina
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
Guidelines on Bladder Cancer Muscle-invasive
Bladder Cancer R. Zenhäusern.
Liver surgery for metachronous hepatic metastases with uterine body and uterine cervix origin – a single center experience Nicolae Bacalbasa (1), Irina.
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Management of Invasive Bladder Cancer
Prognosis of younger patients in non-small cell lung cancer
Urinary bladder cancer
Presentation transcript:

Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital

Bladder tumor ► TCC bladder (90%) ► SCC bladder (7-9%) ► Adenocarcinoma (1-2%) ► Sacroma ► Small cell carcinoma ► Urachal carcinoma

Gading of TCC ► Degree of anaplasia of the tumor cells ► correlation exists between tumor grade and stage Jewett and Strong, 1946 ► correlation between tumor grade and prognosis ► low-grade tumors and high-grade tumors have fundamentally different origins Knowles et al, 1994 ; Spruck et al, 1994 ; Reznikoff et al, 1996 ; Cote and Chatterjee, 1999

Staging of TCC (1997 AJCC-UICC, TNM Staging ) ► Ta: Papillary, epithelium confined ► Tis: Flat carcinoma in situ ► T1: Lamina propria invasion ► T2a: Superficial muscularis propria invasion ► T2b: Deep muscularis propria invasion ► T3a: Microscopic extension into perivesical fat ► T3b: Macroscopic extension into perivesical fat ► T4a: Cancer invading pelvic viscera (e.g., prostatic stroma, vaginal wall, rectum, uterus) ► T4b: Extension to pelvic sidewalls, abdominal walls, or bony

Staging of TCC ► N0: No histologic pelvic node metastases ► N1: Single positive node ≤2 cm in diameter, below common iliacs ► N2: Single positive node 2-5 cm in greatest diameter or multiple positive nodes ► N3: Positive nodes >5 cm in diameter ► Nx: Nodal status unknown ► M0: No distant metastases ► M1: Distant metastases documented ► Mx: Distant metastases status uncertain

PATTERNS OF DISSEMINATION ► Direct Extension ► Lymphatic spread ► Vascular spread ► Implantation

Biology of TCC ► Multicentric Origin  Clonal  Field change ► almost all patients who develop metastases develop muscle-invasive recurrences before or at the time metastases are recognized Jewett and Strong, 1946 ; Freeman et al, 1995a

Treatment decision ► Superficial versus Infiltrating Tumor ?

Non-muscle invasive TCC ► Transurethral Resection of Bladder Tumor (TURBT) ► Intravesical Therapy  BCG  Mitomycin C

Muscle Invasive TCC ► Radical Cystectomy  En bloc cystectomy  Bilateral pelvic iliac lymph node dissection  Urinary diversion

Radical cystectomy ► 69% recurrence-free survival at 5 years ► 60% overall survival at 5 years ► Survival significantly related to pathologic stage and lymph node status ► 9% overall local pelvic recurrence Donald G. Skinner 2007

Complication

Complication ( Local Data ) SOMIP Operative procedure 30day mortality rate Total cystectomy surgery 3.9 Aorta surgery 3.6 Bile duct excision surgery 3.6 Oesophagectomy3.3 Carotid artery surgery 2.9 Major pancreas resection 2.4 Peripheral vascular surgery 2.3 Major heptectomy 1.8 Colorectal Surgery 1.4

Complication ( Local Data ) SOMIP Operative procedure 30day morbidity rate Pharyngolaryngo-esophagectomy64.3 Oesophagectomy55.8 Free flap surgery 38.0 Major pancreas resection 37.3 Liver transplant 36.0 Total cystectomy surgery 36.0 Bile duct excision surgery 35.7 Exploration of CBD and Bypass surgery 34.5 Renal transplant 34.2

Other treatment modality ► Radiation Therapy ► Transurethral Resection ( TUR) ► Combined modality therapy

Partial cystectomy ► Lower surgical risk ► Preservation of bladder function ► Preservation of sexual function ► ??Scarifying survival

Results of Partial cystectomy ► 58 patients undergone Partial cystectomy for primary bladder tumor from 1995 to 2001 in MSK Cancer Centre analyzed ► Overall 5-year survival 69% ► Concomitant CIS and multifocality at high risk of recurrence J M Holzbeierlein et al 2004

Results of Partial Cystectomy ► 37 Patients with muscle invasive urothelial carcinoma underwent partial cystectomy with curative intent in M.D. Anderson Cancer Center ► 5-year overall survival rate 67% ► Higher pathological stage was associated with shorter recurrence-free survival ► Lifelong followup with cystoscopy is recommended W Kassouf et al 2006

highly selective patient highly selective patient ► Solitary mass ► No concomitant CIS ► Adequate surgical margin ► Functional bladder Brannan et al, 1978 Brannan et al, 1978

Conclusion ► Radical cystectomy remain standard therapy of muscle-invasive urothelial bladder cancer ► Survival rate of highly selected patient who undergo partial cystectomy is comparable to those with radical cystectomy ► Lifelong survelliance is required for patient underwent partial cystectomy

Thank you